Longitude Venture Partners L.P., 10% Owner at Esperion Therapeutics, Inc. (ESPR), sold 11,927 shares at $30.04 ($358K) on 2014-10-07, disclosed to the SEC on 2014-10-09.
Scheduled sale ($358k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.04 | 235 | $7K | 2.0% |
| 2 | $30.04 | 11,692 | $351K | 98.0% |
| Total | $30.04 avg | 11,927 | $358K | 100% |
| Filing → |
| CORT | SELL | 2014-04-03 | $1.1M | — | Filing → |